The Age of Precision Medicine
Glen de Vries, co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world, shares insights from his new book coming out on September 14, 2020, titled “The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond”.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Glen de Vries, co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world, shares insights from his new book coming out on September 14, 2020…
- Key Point: Glen de Vries is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world.
- Key Point: Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records.
- Key Point: In 2019, in one of the largest healthcare technology acquisitions in history, Medidata became part of Dassault Systèmes.
- Key Point: Glen has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business t…
Glen de Vries is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest healthcare technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen’s publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University and is the author of The Patient Equation (de Vries & Blachman, 2020).Glen received his undergraduate degree in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center, and studied computer science at New York University’s Courant Institute of Mathematics.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



